The decrease of preoperative autologous transfusion in France has not been linked to an increase of homologous red cell concentrates;La diminution de l'autotransfusion programmée en France ne s'est pas accompagnée d'une augmentation de consommation de concentrés de globules rouges homologues

Annales Francaises d'Anesthesie et de Reanimation

Volumn 27, Issue 2, 2008, Pages 141-147

  Daurat, G ^a   Duedari, N ^b   Schved, J F ^c  

^a Drass   (France)

^b Drass   (France)

^c HÔPITAL SAINT ELOI   (France)

Author keywords

Autologous transfusion; Transfusion; Transfusion hazard

Indexed keywords

ARTICLE; BLOOD AUTOTRANSFUSION; CLINICAL PRACTICE; ERYTHROCYTE CONCENTRATE; FRANCE; HUMAN; PREOPERATIVE PERIOD;

EID: 39149095597     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2007.11.011     Document Type: Article

References (33)

1. Lienhart A., Auroy Y., Clergue F., Laxenaire M.C., Péquignot F., and Jougla E. L'anesthésie en France en 1996. Anesthésies et techniques transfusionnelles. Ann Fr Anesth Réanim 17 (1998) 1374-1386
2. Schved J.F. Faut-il encore faire des transfusions autologues différées programmées ?. Ann Fr Anesth Réanim 23 (2004) 468-473
3. Rosencher N., and Lienhart A. La transfusion autologue programmée (TAP) : faut-il jeter le bébé avec l'eau du bain ?. Ann Fr Anesth Réanim 23 (2004) 457-458
4. Carless P., Moxey A., O'Connell D., and Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med 14 (2004) 123-144
5. Pillonel J., Le Marrec N., Girault A., David D., and Laperche S. Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003. Transfus Clin Biol 12 (2005) 239-246
6. Pillonel J., and Laperche S. Pour le comité de pilotage pour la surveillance épidémiologique des donneurs de sang. Surveillance épidémiologique des donneurs de sang homologues et risque résiduel en France entre 2003 et 2005. BEH 51-52 (2006) 411
7. Brecker M.E., and Goodnough L.T. The rise and fall of preoperative autologous donation. Transfusion 42 (2002) 1618-1622
8. Rapport 2005 de la conférence des coordonnateurs régionaux d'hémovigilance France 2006. http://www.hemovigilance-cncrh.fr/donnees_hemovigilance/rapport_national_2005/rapport-conf-nat-crh.pdf.
9. Ministère de la Santé et des Solidarités, Direction de la recherche, des études de l'évaluaion et des statistiques. L'activité des établissements de santé en 2005 en hospitalisation complète et partielle. Études et résultats ; 2006 Déc: 546. http://www.sante.gouv.fr/drees/etude-resultat/er546/er546.pdf.
10. Billote D.B., Glisson S.N., Green D., and Wixson R.L. A prospective randomised study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg 84 (2002) 1299-1304
11. Muller U., Röder C., Pisan M., Orler R., El-Kerdi A., and Eggli S. Autologous blood donation in total hip arthroplasties is not necessary. Acta Orthop Scand 75 (2004) 66-70
12. Rosencher N., Poisson D., Albi A., Aperce M., Barré J., and Samama C.M. Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anaesth 52 (2005) 160-165
13. Carless P.A., Henry D.A., and Anthony D.M. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev (2003) CD004171
14. Henry D.A., Moxey A.J., Carless P.A., O'Connell D., McClelland B., Henderson K.M., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2001) CD001886
15. Laupacis A., and Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The international study of peri-operative transfusion (ISPOT) investigators. Anesth Analg 85 (1997) 1258-1267
16. Haute autorité de santé. Récupération de sang périopératoire suivie de son administration par voie intraveineuse. Juillet 2006 http://www.has-sante.fr/portail/upload/docs/application/pdf/rspo_rap.pdf.
17. e Congrès national d'Anesthésie et de réanimation. Conférences d'actualisation (2003), Elsevier, Paris 203-218
18. Lienhart A., Auroy Y., Pequignot F., Benhamou D., Warszawski J., Bovet M., et al. Survey of anesthesia-related mortality in France. Anesthesiology 105 (2006) 1087-1097
19. o 199:6-10.
20. Forgie M.A., Wells P.S., Laupacis A., and Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International study of perioperative transfusion (ISPOT) investigators. Arch Intern Med 158 (1998) 610-616
21. Henry D.A., Carless P.A., Moxey A.J., O'Connell D., Forgie M.A., Wells P.S., et al. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2002) CD003602
22. McCarthy J.T., Regnier C.E., Loebertmann C.L., and Bergstralh E.J. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran - a comparison of two products. Am J Nephrol 20 (2000) 455-462
23. Darbepoetin alfa: new indication/new dosage. No proven advantage in chemotherapy-induced anaemia. Prescrire Int 2005; 14:174-6.
24. Evens A.M., Bennett C.L., and Luminari S. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group. Best Pract Res Clin Haematol 18 (2005) 481-489
25. Shermock K.M., Horn E., Lipsett P.A., Pronovost P.J., and Dorman T. Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients. Crit Care Med 33 (2005) 497-503
26. Nowicki M. Related erythropoietin and hypertension. J Hum Hypertens 9 (1995) 81-88
27. Gollman M., Rémy-Prince S., Trépanier A., and Décary F. Autologous donation error rate in Canada. Transfusion 37 (1997) 523-527
28. Rapport hémovigilance Afssaps 2005, http://ile-de-france.sante.gouv.fr/img/pdf/Rapport_IdF_2005.pdf.
29. Popovsky M.A., Whitaker B., and Arnold N.L. Severe outcomes of allogenic and autologous blood donation; frequency and characterization. Transfusion 35 (1995) 734-737
30. Alvarez G.G., Fergusson D.A., Neilipovitz D.T., and Hebert P.C. Cell salvage does not minimize perioperative allogeneic blood transfusion in abdominal vascular surgery: a systematic review. Can J Anaesth 51 (2004) 425-431
31. Madjdpour C., Heindl V., and Spahn D.R. Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiol 72 (2006) 283-298
32. Davies L., Brown T.J., Haynes S., Payne K., Elliott R.A., and McCollum C. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 10 (2006) 1-228
33. TRIP National Haemovigilance Office Den Haag NL: TRIP annual report 2005 http://www.tripnet.nl/pages/en/publicaties.php.